Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenues
Patent licensing fees	$ 250,000	$ 275,000	$ 452,500	$ 397,000
Cost of revenues
Litigation and licensing expenses	327,759	147,393	613,236	237,487
Gross (loss) profit	(77,759)	127,607	(160,736)	159,513
Operating expenses
Selling, general and administrative expenses	598,296	476,812	2,026,057	1,561,987
Total operating expenses	598,296	476,812	2,026,057	1,561,987
Loss from operations	(676,055)	(349,205)	(2,186,793)	(1,402,474)
Other (expense) income
Change in fair market value of warrant liability	59,480	565,928	(154,572)	1,432,145
Interest expense	(216,711)	(113,058)	(570,932)	(295,705)
Total other (expense) income	(157,231)	452,870	(725,504)	1,136,440
Income (loss) before income tax	(833,286)	103,665	(2,912,297)	(266,034)
Income tax expense			(30,000)	(12,884)
Net income (loss)	$ (833,286)	$ 103,665	$ (2,942,297)	$ (278,918)
Income (loss) per share basic (in Dollars per share)	$ (0.16)	$ 0.02	$ (0.55)	$ (0.05)
Weighted average shares outstanding - basic (in Shares)	5,331,973	5,333,347	5,331,973	5,333,347